Index by author
June 2022; Volume 42,Issue 6
Aanes, SIV GYDA
- You have accessSurvival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of CancerCARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLANDAnticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
Abbona, ANDREA
- You have accessEffect of Eribulin on Angiogenesis and the Expression of Endothelial Adhesion MoleculesANDREA ABBONA, MATTEO PACCAGNELLA, SIMONETTA ASTIGIANO, STEFANIA MARTINI, NERINA DENARO, FIORELLA RUATTA, OTTAVIA BARBIERI, MARCO MERLANO and ORNELLA GARRONEAnticancer Research June 2022, 42 (6) 2859-2867; DOI: https://doi.org/10.21873/anticanres.15767
Adachi, TOMOHIKO
- You have accessPrognostic Impact of Relative Dose Intensity of Adjuvant Chemotherapy With S-1 on Pancreatic Ductal AdenocarcinomaHAJIME MATSUSHIMA, TOMOHIKO ADACHI, MASAAKI HIDAKA, MAMPEI YAMASHITA, TAKASHI HAMADA, SAEKO FUKUI, TAKAYUKI TANAKA, HAJIME IMAMURA, KYOHEI YOSHINO, TOTA KUGIYAMA, AMANE KITASATO, TAKANOBU HARA, AKIHIKO SOYAMA, KAZUMA KOBAYASHI, YORIHISA SUMIDA, TAMOTSU KUROKI and SUSUMU EGUCHIAnticancer Research June 2022, 42 (6) 3133-3141; DOI: https://doi.org/10.21873/anticanres.15802
- Open AccessThe Outcome of Conversion Liver Resection Surgery by Lenvatinib Treatment: A Single Center ExperienceMASAAKI HIDAKA, TAKANOBU HARA, AKIHIKO SOYAMA, RYU SASAKI, HAJIME MATSUSHIMA, TAKAYUKI TANAKA, TAKASHI HAMADA, HAJIME IMAMURA, TOMOHIKO ADACHI, KENGO KANETAKA, HISAMITSU MIYAAKI, SHINJI OKANO and SUSUMU EGUCHIAnticancer Research June 2022, 42 (6) 3049-3054; DOI: https://doi.org/10.21873/anticanres.15791
Ahmadi, NIMA
- Open AccessCytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian CentreRAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRISAnticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776
Akahoshi, SHINICHI
- You have accessSuccessful Treatment of Intrahepatic Cholangiocarcinoma With Liver/Lung Metastasis and Peritoneal Dissemination After Liver ResectionKAZUKI MATSUMURA, KENSUKE YAMAMURA, ERI ODA, SHINICHI AKAHOSHI, TAKATOSHI ISHIKO, TATSUNORI MIYATA, HIDEAKI MIYAMOTO, TOSHIHIKO MOTOHARA, AKIRA SASAO, YOSHIHIRO KOMOHARA, HIDECHIKA KAWANO and TORU BEPPUAnticancer Research June 2022, 42 (6) 3209-3215; DOI: https://doi.org/10.21873/anticanres.15811
Akin, IBRAHIM
- You have accessAdverse Cardiovascular Effects of Anti-tumor Therapies in Patients With Breast Cancer: A Single-center Cross-sectional AnalysisSTEPHANIE ROSENKAIMER, TINA SIEBURG, LAURA WINTER, ATHANASIOS MAVRATZAS, WOLF-KARSTEN HOFMANN, RALF-DIETER HOFHEINZ, IBRAHIM AKIN, DANIEL DUERSCHMIED and ANNA HOHNECKAnticancer Research June 2022, 42 (6) 3075-3084; DOI: https://doi.org/10.21873/anticanres.15795
Amico, PAOLO
- You have accessContralateral Interhemispheric Transfalcine Approach for Supratentorial Extraventricular Ependymoma ResectionMATIAS BALDONCINI, GIANLUCA FERINI, GIUSEPPE E. UMANA, BIPIN CHAURASIA, MICKAELA ECHAVARRIA DEMICHELIS, JUAN F. VILLALONGA, PAOLO PALMISCIANO, PAOLO AMICO, SABINO LUZZI, DEREK O. PIPOLO and ALVARO CAMPEROAnticancer Research June 2022, 42 (6) 3203-3207; DOI: https://doi.org/10.21873/anticanres.15810
An, JI YEONG
- You have accessFeasibility of Gastric Tumor Xenograft (GTX)-derived Cell Lines for Individualized Anti-cancer Drug ScreeningSUNG EUN OH, MI YUN OH, SU MI KIM, SUN YOUNG KIM, JI YEONG AN, JUN HO LEE, TAE SUNG SOHN, JAE MOON BAE and MIN-GEW CHOIAnticancer Research June 2022, 42 (6) 2883-2891; DOI: https://doi.org/10.21873/anticanres.15770
Aoki, YOICHI
- You have accessEffects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian CancerTAKUMA OOYAMA, YUKO SHIMOJI, TADAHARU NAKASONE, YOSHIHISA ARAKAKI, YUSUKE TAIRA, TOMOKO NAKAMOTO, WATARU KUDAKA and YOICHI AOKIAnticancer Research June 2022, 42 (6) 3017-3022; DOI: https://doi.org/10.21873/anticanres.15786
Arakaki, YOSHIHISA
- You have accessEffects of Pegylated Liposomal Doxorubicin and CA125 Level Variability Analysis in Platinum-refractory/resistant Recurrent Ovarian CancerTAKUMA OOYAMA, YUKO SHIMOJI, TADAHARU NAKASONE, YOSHIHISA ARAKAKI, YUSUKE TAIRA, TOMOKO NAKAMOTO, WATARU KUDAKA and YOICHI AOKIAnticancer Research June 2022, 42 (6) 3017-3022; DOI: https://doi.org/10.21873/anticanres.15786